山东大学耳鼻喉眼学报 ›› 2019, Vol. 33 ›› Issue (1): 109-113.doi: 10.6040/j.issn.1673-3770.1.2018.028

• 论著 • 上一篇    下一篇

鼻内镜下选择性翼管神经切断术对伴有变应性鼻炎的慢性鼻窦炎的疗效观察

齐岩1,刘俊其1,彭舒娅2,罗凯1,张名霞1,王振霖1   

  1. 1.首都医科大学宣武医院耳鼻咽喉头颈外科, 北京 100053;
    2.北京核工业医院耳鼻咽喉头颈外科, 北京 100045
  • 出版日期:2019-01-20 发布日期:2019-01-28
  • 作者简介:齐岩. E-mail:cherry_1109@126.com

Therapeutic ecacy of endoscopic elective vidian neurectomy for moderate-severe persistent allergic rhinitis with chronic sinusitis

QI Yan1, LIU Junqi1, PENG Shuya2, LUO Kai1, ZHANG Mingxia1, WANG Zhenlin1   

  1. Department of Otorhinolaryngology Head and Neck Surgery, Beijing Hegongye hospital, Beijing 100045, China
  • Online:2019-01-20 Published:2019-01-28

摘要: 目的 探讨鼻内镜下选择性翼管神经切断术治疗伴有中重度变应性鼻炎的慢性鼻窦炎的临床效果。 方法 选择2015年9月至2016年9月在首都医科大学宣武医院就诊的伴有中重度持续性变应性鼻炎(AR)的慢性鼻窦炎鼻息肉的患者132例。所有患者分为两组,对照组62例采取常规手术方法治疗慢性鼻-鼻窦炎,变应性鼻炎选择保守治疗。观察组70例患者在常规手术基础上行选择性翼管神经切断术,包括鼻后神经切断术和翼管神经咽支的切断。应用视觉模拟量表(VAS)、Lund-Kennedy内镜黏膜形态评分、Lund-Mackay鼻窦CT扫描病变范围评分来对术后随访资料收集分析评估,对患者治疗前和治疗结束后随访情况做自身对比,记录治疗前,手术后6个月、1年、2年的数据。 结果 随访2年,对研究终止时随访成功且临床资料完整的106例病例进行分析,观察组56例,对照组50例。观察组病例治疗前VAS评分为(7.6±2.2)分,治疗后6个月VAS评分为(2.3±1.2)分,治疗后1年VAS评分为(2.6±1.7)分,治疗后2年VAS评分为(2.8±1.8)分,与治疗前比较差异均具有统计学意义(P<0.05)。观察组采用选择性翼管神经切断术治疗伴有中重度变应性鼻炎的慢性鼻窦炎总的有效率94.6%(53/56)。与对照组相比差异具有统计学意义(P<0.01)。通过对并发症的统计分析发现观察组未发生泪液分泌障碍、萎缩性鼻炎等并发症。其并发症的发生与对照组比较差异无统计学意义(P>0.05)。将术后2年观察组的疗效评估结果与手术前过敏原检测结果进行相关性分析,显示手术疗效与过敏的严重程度并无明确相关性(P>0.05)。 结论 鼻内镜下选择性翼管神经切断术是治疗伴有中重度持续性变应性鼻炎的慢性鼻窦炎的安全、有效的手段。

关键词: 鼻内镜外科手术, 翼管神经切断, 变应性鼻炎, 慢性鼻-鼻窦炎

Abstract: Objective To evaluate the therapeutic efficacy of endoscopic elective vidian neurectomy in the management of moderate-severe persistent allergic rhinitis with chronic sinusitis and to explore its possible mechanism. Methods One hundred thirty-two patients with moderate-severe persistent allergic rhinitis and chronic sinusitis who visited Xuanwu Hospital Capital Medical University from September 2015 to September 2016 were divided into two groups. Endoscopic elective vidian neurectomy was performed in 70 patients in the observation group, including amputation of the posterior nasal nerve and pharyngeal branch; 62 patients in the control group underwent conventional operation and conservative treatment. The visual analogue scale(VAS)score and Lund-Mackay score were assessed at 6 months, 1 year, and 2 years after operation. Results One hundred and six cases had complete follow-up data. The average VAS score decreased significantly from 7.6±2.2 to 2.3±1.2 at 6 months, to 2.6±1.7 at 1 year, and to 2.8±1.8 at 2 years after operation in the observation group(n= 56, P<0.05). The observation group had a complete control rate of 94.6%(53/56), which was significantly lower than the control group(n=50)at the same period after treatment. There was no severe complication such as xeroma and atrophic rhinitis in both groups. Furthermore, the difference in complications in the observation and control groups was not statistically significant(P>0.05). When correlation analysis of therapeutic efficacy 2 years after operation and the allergen test before operation was performed in the observation group, no significant correlation was observed(P>0.05). Conclusion Endoscopic elective vidian neurectomy is an effective and safe technique in the management of moderate-severe persistent allergic rhinitis with chronic sinusitis.

Key words: Nasal endoscopic surgical procedures, operative, Vidian neurectomy, Allergic rhinitis, Chronic sinusitis

中图分类号: 

  • R765
[1] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎诊断和治疗指南(2015年,天津)[J].中华耳鼻咽喉头颈外科杂志,2016,51(1):6-24.
[2] Greiner AN, Hellings PW, Rotiroti G, et al. Allergic rhinitis[J]. Lancet, 2011, 378(9809):2112-2122. doi:10.1016/S0140-6736(11)60130-X.
[3] 谭国林, 马艳红, 刘更盛, 等. 鼻内镜下翼管神经切断术治疗中-重度持续性变应性鼻炎的远期临床疗效[J]. 中华耳鼻咽喉头颈外科杂志, 2011, 46(6):449-454. doi:10.3760/cma.j.issn.1673-0860.2011.06.003. TAN Guolin, MA Yanhong, LIU Gengsheng, et al. Therapeutic effect of endoscopic vidian neurectomy on moderate-severe persistent allergic rhinitis[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2011, 46(6):449-454. doi:10.3760/cma.j.issn.1673-0860.2011.06.003.
[4] 冀永进, 张艳廷, 赵长青, 等. 鼻内镜下经蝶窦翼管神经切断术的手术探讨[J]. 中国耳鼻咽喉颅底外科杂志, 2014, 20(6):483-486. doi:10.11798/j.issn.1007-1520.201406004. JI Yongjin, ZHANG Yanting, ZHAO Changqing, et al. A modified endoscopic transsphenoidal vidian neurectomy[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2014, 20(6):483-486. doi:10.11798/j.issn.1007-1520.201406004.
[5] Fokkens W J, Lund V J, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012.[J]. Rhinol Suppl, 2012, 23(3):1-298.
[6] 中华医学会耳鼻咽喉科学分会,中华耳鼻咽喉科杂志编辑委员会.慢性鼻窦炎鼻息肉临床分型分期及内窥镜鼻窦手术疗效评定标准(1997年,海口)[J].中华耳鼻咽喉科杂志,1998,33(3):134-135.
[7] 金加欣, 殷敏, 程雷. 慢性鼻-鼻窦炎诊断和治疗指南(2012年,昆明)解读[J]. 中国中西医结合耳鼻咽喉科杂志, 2013, 21(5):388-391. doi:10.3969/j.issn.1007-4856.2013.05.021.
[8] Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey[J]. J Allergy Clin Immunol, 2009, 124(3 Suppl):S43-S70. doi:10.1016/j.jaci.2009.05.013.
[9] 朱亚琼, 刘月辉. 2型固有淋巴细胞和miR-155在变应性鼻炎中的研究现状[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(24):1940-1943. doi:10.13201/j.issn.1001-1781.2017.24.019. ZHU Yaqiong, LIU Yuehui. A review on group 2 innate lymphoid cells and miR-155 in allergic rhinitis[J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2017, 31(24):1940-1943. doi:10.13201/j.issn.1001-1781.2017.24.019.
[10] 赵长青, 张艳廷, 何敏. 翼管神经切断术在变应性鼻炎治疗中的作用[J]. 中华耳鼻咽喉头颈外科杂志, 2017, 52(7):484-490. doi:10.3760/cma.j.issn.1673-0860.2017.07.002. ZHAO Changqing, ZHANG Yanting, HE Min. Effects of vidian neurectomy on allergic rhinitis[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2017, 52(7):484-490. doi:10.3760/cma.j.issn.1673-0860.2017.07.002.
[11] 李超, 曹永华, 张艳廷, 等. 鼻内镜下手术治疗鼻高反应性疾病进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(1):77-81. doi:10.6040/j.issn.1673-3770.0.2017.324 LI Chao, CAO Yonghua, ZHANG Yanting, et al. Nasal endoscopy in the treatment of nasal mucosal hyperreactive rhinopathy[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(1):77-81. doi:10.6040/j.issn.1673-3770.0.2017.324
[12] Undem BJ, Taylor-Clark T. Mechanisms underlying the neuronal-based symptoms of allergy[J]. J Allergy Clin Immunol, 2014, 133(6):1521-1534. doi:10.1016/j.jaci.2013.11.027.
[13] 谭国林. 难治性变应性鼻炎的外科治疗[J]. 中国耳鼻咽喉颅底外科杂志, 2016, 22(1):1-4. doi:10.11798/j.issn.1007-1520.201601001.
[14] 黄钦辉, 阙镇如. 鼻内镜下翼管神经切断术治疗持续性变应性鼻炎近远期疗效[J]. 中国实用神经疾病杂志, 2015, 18(12):95-96. doi:10.3969/j.issn.1673-5110.2015.12.062.
[15] 陈江波, 谭国林. 鼻内窥镜下翼管神经切断术对血管运动性鼻炎的治疗作用[J]. 中南大学学报(医学版), 2007, 32(5):913-916. doi:10.3321/j.issn:1672-7347.2007.05.036. CHEN Jiangbo, TAN Guolin. Therapeutic effect of vadian neurectomy under the nasal endoscope on the vasomotor rhinitis[J]. Journal of Central South University(Medical Science), 2007, 32(5):913-916. doi:10.3321/j.issn:1672-7347.2007.05.036.
[16] Ikeda K, Yokoi H, Saito T, et al. Effect of resection of the posterior nasal nerve on functional and morphological changes in the inferior turbinate mucosa[J]. Acta Otolaryngol, 2008, 128(12):1337-1341. doi:10.1080/00016480801935525.
[17] Ogawa T, Takeno S, Ishino T, et al. Submucous turbinectomy combined with posterior nasal neurectomy in the management of severe allergic rhinitis: clinical outcomes and local cytokine changes[J]. Auris Nasus Larynx, 2007, 34(3):319-326. doi:10.1016/j.anl.2007.01.008.
[18] Kanaya T, Kikawada T. Endoscopic posterior nasal neurectomy: an alternative to Vidian neurectomy[J]. Clin Exper Allergy Rev, 2009, 9(1):24-27. doi:10.1111/j.1472-9733.2009.01145.x.
[19] Bleier BS, Schlosser RJ. Endoscopic anatomy of the postganglionic pterygopalatine innervation of the posterolateral nasal mucosa[J]. Int Forum Allergy Rhinol, 2011, 1(2):113-117. doi:10.1002/alr.20011.
[1] 冯思聪,于晓岚,娄丹. 基于囊泡组织Ki67、GM-CSF表达评估Messerklinger中鼻甲成形术对慢性鼻-鼻窦炎合并鼻息肉的效果[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 31-39.
[2] 吕倩,唐源,顾子君,施赛磊,刘萍,万文锦. 变应性鼻炎患者疾病获益感现状及影响因素分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 21-28.
[3] 顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111.
[4] 秦娜娜,李玉芬,孙雨浩,魏健,李钦. 基于TGF-β1/Smad信号通路探讨白细胞介素13受体α2对变应性鼻炎大鼠鼻黏膜组织重塑的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 71-77.
[5] 熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[6] 许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33.
[7] 刘怡君,谷悦,官大宇,杨玉成,沈暘. 翼管神经切断术在难治性变应性鼻炎中远期临床疗效和安全性[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 42-48.
[8] 张婷,王美兰,高映勤. 白细胞介素35在变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 139-147.
[9] 张竹萍,彭孜灿,肖振龙,李程,喻迪,王兴龙,陈伟,郭蓓. 新型鼻分泌物嗜酸粒细胞阳离子蛋白-髓过氧化物酶试纸在变应性鼻炎中的应用价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 129-134.
[10] 曹正勇,李小波. 慢性鼻-鼻窦炎合并哮喘术后短程局部使用糖皮质激素辅助治疗的安全性和有效性[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 43-50.
[11] 刘畅,杨景朴,高雨,王文佳. 长春地区儿童变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 51-58.
[12] 周荷青,申琪. 中医药治疗变应性鼻炎疗效的生物标志物研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 168-176.
[13] 王曼娴,郑泉,杨亮. 细菌裂解物治疗变应性鼻炎的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 141-145.
[14] 刘畅,方宏艳,刘敩,富东娜,王贺,王晶,杨景朴. 长春地区秋季变应性鼻炎蒿属花粉致敏特征分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 13-19.
[15] 朱朗,刘志奇. 移动医疗提供的真实世界数据在变应性鼻炎治疗方案中的参考[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 135-139.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!